Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR | ||
| Cardiovascular Research Prove Journal | ||
| Volume 6, Issue 2, December 2022 PDF (97.84 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/cvrepj.2022.351488 | ||
| Abstract | ||
| Microvascular obstruction (MO) or no-reflow phenomenon is an established complication of coronary reperfusion therapy for acute myocardial infarction. | ||
|
Statistics Article View: 72 PDF Download: 38 |
||
